SRRT and lymphoma: Ars2 BAR‐bodies in IgG1 format had no effect on HBL‐1 lymphoma cells, which are also DLBCL cells but expressing a BCR of unknown reactivity and also not on both MCL cell lines MAVER‐1 and Granta‐519.